#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14446	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2310	755.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1566	1566	C	927	C,T	926,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23802	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4128	718.6	0	.	n	.	0	T695C	SNP	695	695	T	1333	1333	C	894	C,T,A,G	889,2,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23802	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4128	718.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1975	1975	A	914	A,G	912,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23802	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4128	718.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2609	2609	C	848	C,T,G,A	842,1,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23802	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4128	718.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2683	2683	A	757	A	757	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23802	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4128	718.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	3235	3235	C	841	C,A	840,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1990	folP	855	855	100.0	folP.l6.c4.ctg.1	2061	120.2	1	SNP	p	R229S	1	.	.	685	687	AGC	1331	1333	AGC	189;188;189	A;G;C	189;188;189	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4918	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3941	155.4	1	SNP	p	S91F	1	.	.	271	273	TTC	850	852	TTC	182;181;180	T;T;C,A	182;181;179,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4918	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3941	155.4	1	SNP	p	G95N	0	.	.	283	285	GGC	862	864	GGC	188;189;191	G;G,C;C	188;188,1;191	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4918	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3941	155.4	1	SNP	p	D95G	1	.	.	283	285	GGC	862	864	GGC	188;189;191	G;G,C;C	188;188,1;191	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1840	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1831	124.8	1	SNP	p	G45D	0	.	.	133	135	GGC	692	694	GGC	192;194;191	G,A;G;C	191,1;194;191	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1062	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1384	95.2	0	.	n	.	0	A197.	DEL	197	197	A	778	778	A	209	A,G	207,2	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4632	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3492	165.4	1	SNP	p	D86N	0	.	.	256	258	GAC	881	883	GAC	185;184;188	G;A;C	184;183;187	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4632	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3492	165.4	1	SNP	p	S87R	1	.	.	259	261	CGT	884	886	CGT	185;186;188	C;G,A;T	185;183,2;187	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4632	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3492	165.4	1	SNP	p	R87W	0	.	.	259	261	CGT	884	886	CGT	185;186;188	C;G,A;T	185;183,2;187	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4632	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3492	165.4	1	SNP	p	R87I	0	.	.	259	261	CGT	884	886	CGT	185;186;188	C;G,A;T	185;183,2;187	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4632	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3492	165.4	1	SNP	p	S88P	0	.	.	262	264	TCC	887	889	TCC	188;187;187	T;C;C	188;187;187	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4142	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3008	171.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1746	1748	GGC	237;237;236	G;G,A;C,G	237;236,1;235,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3914	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2805	173.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1442	1444	GCA	214;212;212	G,C;C;A	213,1;212;212	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3914	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2805	173.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1445	1447	ATC	213;218;218	A;T,G;C,T	213;217,1;217,1	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3914	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2805	173.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1457	1459	GTG	228;227;230	G;T,A;G	228;226,1;230	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3914	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2805	173.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1457	1459	GTG	228;227;230	G;T,A;G	228;226,1;230	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3914	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2805	173.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1961	1963	ACC	224;225;227	A,G;C,G;C,T	223,1;224,1;226,1	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3914	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2805	173.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2015	2017	GCG	203;200;198	G;C,G;G	202;198,1;197	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3914	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2805	173.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2015	2017	GCG	203;200;198	G;C,G;G	202;198,1;197	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3914	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2805	173.5	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2138	2140	AGC	211;212;210	A,C;G;C	210,1;212;210	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3914	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2805	173.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2147	2149	GGC	211;211;211	G;G;C	211;211;211	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3914	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2805	173.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2165	2167	CCG	220;222;221	C,T,A;C,T;G	218,1,1;221,1;221	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5244	ponA	2397	2397	100.0	ponA.l6.c17.ctg.1	3395	191.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1737	1739	CCG	224;223;222	C;C,A;G	224;222,1;222	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2350	porA	1146	1146	99.91	porA.l15.c30.ctg.1	2385	122.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	853	853	C	183	C,T	182,1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	290	porB1a	984	100	95.0	porB1a.l15.c17.ctg.4	174	54.1	0	.	p	.	0	M18T	NONSYN	52	54	ATG	125	127	ACG	59;56;54	A;C;G	59;56;54	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	290	porB1a	984	100	95.0	porB1a.l15.c17.ctg.4	174	54.1	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	167	169	CAA	14;12;9	C;A;A	14;12;9	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2826	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1897	184.6	0	.	p	.	0	N38E	NONSYN	112	114	AAT	606	608	GAA	246;245;242	G;A,C;A	246;244,1;242	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2826	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1897	184.6	0	.	p	.	0	N134D	NONSYN	400	402	AAT	894	896	GAT	244;244;240	G,C;A;T,G	242,1;243;238,2	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2826	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1897	184.6	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1017	1019	TCA	255;254;252	T;C,G;A	255;253,1;252	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2826	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1897	184.6	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1146	1148	GTC	242;243;238	G;TCCCC,TCCC,TCC;C	242;226,2,1;238	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2826	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1897	184.6	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1476	1478	GCA	185;185;183	G,C;C,A;A	184,1;183,2;183	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2826	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1897	184.6	1	SNP	p	G120K	1	.	.	358	360	AAG	852	854	AAG	253;252;252	A;A;G	253;252;252	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2826	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1897	184.6	1	SNP	p	A121D	1	.	.	361	363	GAC	855	857	GAC	252;253;256	G,C;A;C,T	251,1;253;255,1	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2826	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1897	184.6	1	SNP	p	D121N	0	.	.	361	363	GAC	855	857	GAC	252;253;256	G,C;A;C,T	251,1;253;255,1	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9562	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	5479	217.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1348	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1544	108.9	1	SNP	p	V57M	1	.	.	169	171	ATG	801	803	ATG	242;243;242	A;T,G;G	242;242,1;242	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
